Canopy Growth (CGC) Short-term Investments (2017 - 2026)
Canopy Growth (CGC) posted Short-term Investments of $4.2 million for Q2 2025, down 65.82% sequentially from $12.3 million in Q1 2025, and down 25.2% YoY from $5.6 million in Q2 2024.
Canopy Growth (CGC) Short-term Investments (2017 - 2026) Analysis & Trends
Canopy Growth has reported Short-term Investments for 9 years, with the latest figure at $4.2 million in Q2 2025.
- Quarterly Short-term Investments fell 25.2% year-over-year to $4.2 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $4.2 million (down 25.2% YoY) and the FY2025 annual result came in at $12.3 million, up 126.82% from the prior year.
- Short-term Investments declined to $4.2 million in Q2 2025 per CGC's latest filing, from $12.3 million in the prior quarter.
- Over five years, Short-term Investments peaked at $640.9 million in Q4 2021 and troughed at $4.2 million in Q2 2025.
- A 5-year average of $147.5 million and a median of $12.0 million in 2024 frame the typical range for Short-term Investments.
- The widest YoY moves for Short-term Investments: up 3382.69% in 2021, down 98.48% in 2021.
- Over 5 years, Short-term Investments stood at $640.9 million in 2021, then plunged by 78.03% to $140.8 million in 2022, then tumbled by 77.34% to $31.9 million in 2023, then plunged by 63.13% to $11.8 million in 2024, then slumped by 64.25% to $4.2 million in 2025.
- According to Business Quant data, Short-term Investments over the past three periods registered $4.2 million, $12.3 million, and $11.8 million for Q2 2025, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Canopy Growth | 441.27 Mn | 194.25 Mn | 16.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.66 Mn |
| Mar 31, 2026 | 3.68 Mn |
| Dec 31, 2025 | 3.61 Mn |
| Sep 30, 2025 | 4.11 Mn |
| Jun 30, 2025 | 4.21 Mn |
| Mar 31, 2025 | 12.30 Mn |
| Dec 31, 2024 | 11.76 Mn |
| Sep 30, 2024 | 5.49 Mn |
| Jun 30, 2024 | 5.62 Mn |
| Mar 31, 2024 | 5.42 Mn |
| Dec 31, 2023 | 31.91 Mn |
| Sep 30, 2023 | 5.96 Mn |
| Jun 30, 2023 | 6.80 Mn |
| Mar 31, 2023 | 78.06 Mn |
| Dec 31, 2022 | 140.80 Mn |
| Sep 30, 2022 | 304.17 Mn |
| Jun 30, 2022 | 351.09 Mn |
| Mar 31, 2022 | 470.25 Mn |
| Dec 31, 2021 | 640.92 Mn |
| Sep 30, 2021 | 9.71 Mn |